Levetiracetam Fairmed Healthcare

Levetiracetam, the active ingredient in Levetiracetam Fairmed Healthcare, is an anticonvulsant presented as a tablet for oral use. It treats partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Fairmed Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication used to control seizure activity in various epilepsy syndromes. - Partial seizures: reduces the frequency of focal onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: decreases occurrence of sudden muscle jerks.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: feeling of light‑headedness or unsteadiness. - Fatigue: unusual tiredness or lack of energy. - Headache: mild to moderate cranial pain. - Irritability: increased mood swings or agitation.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, suicidal thoughts, or aggression. - Hematologic abnormalities: low blood counts or platelet disorders.

When prescribing levetiracetam, clinicians should consider several safety precautions. - Renal impairment: adjust dose in patients with reduced kidney function. - History of psychiatric disorders: monitor for mood changes or suicidal ideation. - Concomitant CNS depressants: use caution as additive sedation may occur. - Pregnancy: evaluate risk‑benefit as safety data are limited. - Elderly patients: start with lower dose and monitor tolerability. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels, decreasing seizure control. - Phenobarbital: can lower levetiracetam concentrations, potentially compromising effectiveness.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam levels, requiring monitoring for side effects. - Alcohol: additive CNS depression may enhance dizziness or sedation. - Other antiepileptics (e.g., lamotrigine): combined therapy may increase adverse effect risk.